Telling.ai is a company.
Telling.ai has raised $50K across 1 funding round.
Key people at Telling.ai.
Telling.ai was founded by Brian Goler (Co-Founder).
Telling.ai has raised $50K in total across 1 funding round.
Key people at Telling.ai.
Telling.ai was founded by Brian Goler (Co-Founder).
Telling.ai has raised $50K in total across 1 funding round.
Telling.ai's investors include Innovation Works.
Telling.ai is a Pittsburgh-based startup developing AI-powered voice analytics software focused on monitoring lung health through speech analysis. It targets individuals at risk for respiratory conditions like COPD, asthma, shortness of breath, and COVID-19, as well as enterprise clients, by detecting unique auditory signatures of issues such as mucus, obstruction, congestion, inflammation, and scarring in breath and speech.[1][4] The platform extracts dozens of undetectable features to enable real-time feedback, data denoising, and timely interventions, aiming to reduce the 1.5 million annual U.S. Emergency Department visits and 800,000 hospitalizations from COPD alone, where nearly 20% of acute exacerbation patients are readmitted within 30 days.[4]
Limited public details exist on Telling.ai's founders or exact founding year, but the company operates from physical offices in Pittsburgh, Pennsylvania, emphasizing an onsite workspace.[1] Its emergence aligns with rising demand for non-invasive respiratory monitoring post-COVID, leveraging speech—a complex process involving lungs, airways, nerves, and muscles—as a diagnostic tool with medical signatures for infections and diseases.[4] Early focus appears on real-world applications, building a framework for capturing respiratory sounds outside clinical settings, which has positioned it for healthcare impact amid growing AI healthtech adoption.[1][4]
Telling.ai rides the AI healthtech wave, capitalizing on voice AI's non-invasive potential amid post-pandemic respiratory awareness and aging populations vulnerable to COPD and asthma. Timing is ideal as AI analytics advance in detecting subclinical signals, aligning with market forces like rising healthcare costs—COPD drives massive ED and hospital burdens—and demand for remote monitoring to cut readmissions.[4] It influences the ecosystem by pioneering speech as a vital sign, potentially expanding to other diseases, and complements enterprise tools in logistics, healthtech, and BI sectors hiring similar AI talent.[1]
Telling.ai is poised to scale its voice analytics from niche respiratory monitoring to broader AI diagnostics, fueled by improving algorithms and real-world data. Trends like wearable integration, multimodal AI (combining voice with wearables), and regulatory nods for AI health tools will shape its path, amplifying preventive care amid chronic disease epidemics. Its influence may grow by partnering with telehealth giants, evolving from Pittsburgh innovator to key player in reducing U.S. healthcare spend—echoing its core mission to enable timely interventions through everyday speech.[4]
Telling.ai has raised $50K across 1 funding round. Most recently, it raised $50K Seed in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2021 | $50K Seed | Innovation Works |
